Treatment of Hemorrhoids with Unani formulations Habbe Rasuat, Habb-e- Muqil, Habb-e- Papita and Marham e Saeeda Chob Neem Wala.
- Conditions
- Unspecified hemorrhoids,
- Registration Number
- CTRI/2013/10/004069
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
This study is designed as a multicentric open trial in patients with BAWASEER-E-DAMIYA (Hemorrhoids). After screening, Patients will be enrolled if they satisfy following inclusion and exclusion criteria. The patients will be assessed clinically on each fortnightly follow up. This includes subjective assessment of general well being and physical examination. The total duration of treatment will be 6 weeks and the follow-up for all clinical parameters will be conducted every two weeks. Laboratory parameters for safety assessment will be conducted at baseline and end of study.
**Bawaseer e Damia**
| | | |
| --- | --- | --- |
|Habb-e-Rasaut
|S.No
Name
Quantity
|1
Rasaut
50 g.
|2
Kateera
20 g.
|3
Mazu
10 g.
|4
Sang-e-Jarahat
10 g.
|5
Geru
10 g.
| | | |
| --- | --- | --- |
|Majoon-e-Muqil
|S.No
Name
Quantity
|1
Post-e-Halela Kabli
10 g.
|2
Post-e-Balela
10 g.
|3
Aamla
10 g.
|4
Dana Heel Khurd
10 g.
|5
Badiyan
10 g.
|6
Nankhwah
5 g.
|7
Sazaj Hindi
5 g.
|8
Narmushk
5 g.
|9
Zanjabeel
5 g.
|10
Satar Farsi
5 g.
|11
Waj-e-Turki
5 g.
|12
Filfil Daraz
5 g.
|13
Muqil
85 g.
|14
Asal OR Qand Safaid
350 g.
Habbe Muqil
| | | |
| --- | --- | --- |
|S.No
Name
Quantity
|1.
Post Halela-e-Zard
300 g.
|2.
Turbud Safaid
100 g.
|3.
Rai
20 g.
|4.
Tukhm Gandana
50 g.
|5.
Gugal
150 g.
|6.
Halela Siyah
150 g.
**Marham SaeedaChob Neemwala**
| | | |
| --- | --- | --- |
|S.No
Name
Quantity
|7.
Post Bakayin
10 g.
|8.
Post Neem
10 g.
|9.
Rasaut Musaffa
10 g.
|10.
Safaida Kashghari
10 g.
|11.
Gugal
10 g.
|12.
Maghaz Bakayin
10 g.
|13.
Maghaz Neem
10 g.
|14.
Kafoor
10 g.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 300
1.The patients of either sex in the age group of 18 to 65 years 2.Patients having the following symptoms and signs of the disease •Rectal Bleeding •First and Second Degree Hemorrhoids •Pruritus Ani •Rectal and Anal Pain.
- 1.Patients below 18 years and above 65 years of age 2.Patients with Third and Fourth Degree Haemorrhoids 3.Patients with Anal fissures 4.Patients with other long term diseases/ disorders 5.Malnourished Patients (BMI of 18.5 kg/m2 and Haemoglobin 12 g/dL) 6.Patients with Inflammatory Bowel Disease(Ulcerative colitis, Crohn,s disease etc).
- 7.Pregnant and Lactating Women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms 6 WEEKS
- Secondary Outcome Measures
Name Time Method HAEMATOLOGICAL AND BIOCHEMICAL ASSESMENT OF LABORATORY PARAMETERS 6 WEEKS
Trial Locations
- Locations (3)
REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE
🇮🇳Delhi, DELHI, India
Regional Research Institute of Unani Medicine (RRIUM), Bhadrak
🇮🇳Bhadrak, ORISSA, India
Regional Research Institute of Unani Medicine (RRIUM), Kolkata
🇮🇳Kolkata, WEST BENGAL, India
REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE🇮🇳Delhi, DELHI, IndiaDR RASHIDULLAH KHANPrincipal investigator01126952759rriumdelhi@gmail.com